Research has implications for understanding brain diseases caused by clumps of misshapen molecules
It's almost axiomatic that misfolded proteins compromise how cells normally function and cause debilitating human disease, but how these proteins are detected and degraded within the body is not well understood. Neurodegenerative diseases – including Alzheimer's disease, Parkinson's disease, amyotrophic lateral sclerosis (Lou Gehrig's disease), Huntington's disease, and spinocerebellar ataxias – exact a devastating toll on aging populations throughout the world.
This is a model for protein quality control by the PML-RNF4 system.
Credit: Lili Guo, Ph.D., Perelman School of Medicine, University of Pennsylvania; Molecular Cell
"Yet, there is virtually no cure for any of these diseases, and clinical trials have yielded mostly disappointing results, indicating that investigators are missing something fundamental about these diseases," says Xiaolu Yang, PhD, professor of Cancer Biology, Perelman School of Medicine at the University of Pennsylvania. All of these diseases are caused by the accumulation of toxic misfolded proteins in different types of neurons. "However, our knowledge about how cells normally remove these proteins, an issue fundamental to understanding what goes wrong in neurodegenerative diseases, is very limited."
Yang and first author Lili Guo, PhD, who was a doctoral student in the Yang lab, identified a protein recycling pathway in mammalian cells that removes misfolded proteins. Their findings appear online today in Molecular Cell ahead of the print edition. They also demonstrated this pathway's role in protecting against neurodegenerative diseases in an animal model. Guo is now a postdoctoral fellow in another Perelman School lab.
Proteins are the work horses of the cells. They are the most abundant macromolecules, extremely versatile in their functions and critically important for virtually all biological processes. However, proteins are also highly prone to misfolding due to genetic mutations, synthetic inaccuracies, and irreparable damages. What's more, the half-life of many proteins is relatively short, from a few minutes to a few hours, necessitating their continued synthesis. As such this puts a burden on the cell to maintain quality control in the correct folding of proteins.
"This paper resolves a long-standing question in protein quality control of how misfolded proteins are precisely selected for degradation," notes Yang. "This newly described system could be a valuable target for treating neurodegenerative diseases."
In any normally functioning cell, two systems maintain protein quality. First, chaperone proteins, like fingers that fold paper into origami shapes, guide amino acid chains in folding into their final, proper protein forms. Second, the recycling systems dispose of misfolded proteins and ultimately breaks them up into individual amino acids. This system involves the proteasome, a protein complex found throughout the cytoplasm and nucleus of cells. "But it is unclear how misshapen proteins are recognized and shuttled to the proteasome to be degraded. This study moves the field forward because we showed that the system is common for many types of misfolded proteins," notes Yang.
In addition to identifying the step-by-step molecular players of the system that eliminates misfolded proteins, they also defined the system's method of action. The mechanism of action is a relay system with two proteins.
The first protein, PML/TRIM19, recognizes features of misfolded proteins such as exposed water-phobic inner cores, which stick out and enhance the forming of toxic protein clumps. PML selectively interacts with misfolded proteins by recognizing this and other distinct features and tags the misfolded proteins with chains of a small protein called SUMO (small ubiquitin-like modifier). The SUMO-modified misfolded proteins are then recognized by the second protein, RNF4, which tags them with chains of another small protein called ubiquitin. The ubiquitin chain is a signal that can be recognized by the barrel-shaped proteasome, leading to the degradation of misfolded proteins.
The team then went on to demonstrate the physiological importance of the elimination system using a mouse model of spinocerebellar ataxia 1 (SCA1), a fatal neurological disorder that causes problems with movement and balance. Mutations in the ATXN1 gene cause SCA1, which involves repeated segments of the DNA building blocks cytosine (C), adenine (A), and guanine (G) that appear multiple times in a row in the gene, which encodes a tract of contiguous glutamine amino acids. Normally, the CAG segment is repeated 4 to 39 times within the gene. In SCA1, the CAG segment is repeated 40 to more than 80 times, which leads to an abnormally long ataxin-1 protein that folds into the wrong 3-dimensional shape and forms clumps within the nucleus. The team showed that a PML deficiency exacerbates both the behavioral and neuropathological defects caused by the expanded CAG repeat in the SCA1 mouse, indicating that PML normally operates to protect against neurodegeneration.
The PML protein is also involved in the formation of tumors, and that's how Yang, a cancer biologist, got involved in this type of research.
"The knowledge gained from this project now provides for the possibility of new therapeutic targets for neurodegenerative diseases. Perhaps new drugs could enhance the elimination system by increasing the action of PML or RNF4, or could inhibit the inhibitors of the SUMO and ubiquitin tagging process," says Yang
Other co-authors are Alex Glavis-Bloom, Michael D. Brewer, James Shorter, Aaron D. Gitler, now at Stanford Medical Center, and Benoit I. Giasson, now at the University of Florida.
The research was supported in part by grants from the National Cancer Institute (CA088868) and the National Institute of General Medical Sciences (GM060911).
Penn Medicine is one of the world's leading academic medical centers, dedicated to the related missions of medical education, biomedical research, and excellence in patient care. Penn Medicine consists of the Raymond and Ruth Perelman School of Medicine at the University of Pennsylvania (founded in 1765 as the nation's first medical school) and the University of Pennsylvania Health System, which together form a $4.3 billion enterprise.
The Perelman School of Medicine has been ranked among the top five medical schools in the United States for the past 17 years, according to U.S. News & World Report's survey of research-oriented medical schools. The School is consistently among the nation's top recipients of funding from the National Institutes of Health, with $392 million awarded in the 2013 fiscal year.
The University of Pennsylvania Health System's patient care facilities include: The Hospital of the University of Pennsylvania -- recognized as one of the nation's top "Honor Roll" hospitals by U.S. News & World Report; Penn Presbyterian Medical Center; Chester County Hospital; Penn Wissahickon Hospice; and Pennsylvania Hospital -- the nation's first hospital, founded in 1751. Additional affiliated inpatient care facilities and services throughout the Philadelphia region include Chestnut Hill Hospital and Good Shepherd Penn Partners, a partnership between Good Shepherd Rehabilitation Network and Penn Medicine.
Penn Medicine is committed to improving lives and health through a variety of community-based programs and activities. In fiscal year 2013, Penn Medicine provided $814 million to benefit our community.
Karen Kreeger | Eurek Alert!
Nanoparticle Exposure Can Awaken Dormant Viruses in the Lungs
16.01.2017 | Helmholtz Zentrum München - Deutsches Forschungszentrum für Gesundheit und Umwelt
Cholera bacteria infect more effectively with a simple twist of shape
13.01.2017 | Princeton University
Researchers from the University of Hamburg in Germany, in collaboration with colleagues from the University of Aarhus in Denmark, have synthesized a new superconducting material by growing a few layers of an antiferromagnetic transition-metal chalcogenide on a bismuth-based topological insulator, both being non-superconducting materials.
While superconductivity and magnetism are generally believed to be mutually exclusive, surprisingly, in this new material, superconducting correlations...
Laser-driving of semimetals allows creating novel quasiparticle states within condensed matter systems and switching between different states on ultrafast time scales
Studying properties of fundamental particles in condensed matter systems is a promising approach to quantum field theory. Quasiparticles offer the opportunity...
Among the general public, solar thermal energy is currently associated with dark blue, rectangular collectors on building roofs. Technologies are needed for aesthetically high quality architecture which offer the architect more room for manoeuvre when it comes to low- and plus-energy buildings. With the “ArKol” project, researchers at Fraunhofer ISE together with partners are currently developing two façade collectors for solar thermal energy generation, which permit a high degree of design flexibility: a strip collector for opaque façade sections and a solar thermal blind for transparent sections. The current state of the two developments will be presented at the BAU 2017 trade fair.
As part of the “ArKol – development of architecturally highly integrated façade collectors with heat pipes” project, Fraunhofer ISE together with its partners...
At TU Wien, an alternative for resource intensive formwork for the construction of concrete domes was developed. It is now used in a test dome for the Austrian Federal Railways Infrastructure (ÖBB Infrastruktur).
Concrete shells are efficient structures, but not very resource efficient. The formwork for the construction of concrete domes alone requires a high amount of...
Many pathogens use certain sugar compounds from their host to help conceal themselves against the immune system. Scientists at the University of Bonn have now, in cooperation with researchers at the University of York in the United Kingdom, analyzed the dynamics of a bacterial molecule that is involved in this process. They demonstrate that the protein grabs onto the sugar molecule with a Pac Man-like chewing motion and holds it until it can be used. Their results could help design therapeutics that could make the protein poorer at grabbing and holding and hence compromise the pathogen in the host. The study has now been published in “Biophysical Journal”.
The cells of the mouth, nose and intestinal mucosa produce large quantities of a chemical called sialic acid. Many bacteria possess a special transport system...
10.01.2017 | Event News
09.01.2017 | Event News
05.01.2017 | Event News
17.01.2017 | Earth Sciences
17.01.2017 | Materials Sciences
17.01.2017 | Architecture and Construction